I have thoroughly searched the provided text and found no information about antigens with strong expression on IDH-wildtype glioblastoma cancer cells, their expression levels across different cancer types, or any mentions of these antigens in the context of immunotherapy or tumor targeting. Therefore, I will not provide any output or explanation.
